Ngā hua rapu kaituhi

1

Pathological and molecular diagnosis of triple-negative breast cancer: a clinical perspective mā Frédérique Penault‐Llorca, Giuseppe Viale

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

aHIF but not HIF-1α transcript is a poor prognostic marker in human breast cancer mā Anne Cayre, Fabrice Rossignol, Eric Clottes, Frédérique Penault‐Llorca

I whakaputaina 2003

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

Testing algorithm for identification of patients with TRK fusion cancer mā Frédérique Penault‐Llorca, Erin R. Rudzinski, Antonia R. Sepulveda

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
4

Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells mā Abderrahim El Guerrab, Mahchid Bamdad, Yves‐Jean Bignon, Frédérique Penault‐Llorca, Corinne Aubel

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Treatment of gastric adenocarcinoma: A rapidly evolving landscape mā Julien Taı̈eb, Jaafar Bennouna, Frédérique Penault-Llorca, Debora Basile, Emmanuelle Samalin, Aziz Zaanan

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
6

Experts' opinion: Recommendations for retesting breast cancer metastases for HER2 and hormone receptor status mā Frédérique Penault‐Llorca, Renata A. Coudry, Wedad Hanna, R. Yoshiyuki Osamura, Josef Rüschoff, Giuseppe Viale

I whakaputaina 2013

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer mā Abderrahim El Guerrab, Mahchid Bamdad, Fabrice Kwiatkowski, Yves‐Jean Bignon, Frédérique Penault‐Llorca, Corinne Aubel

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up mā Fátima Cardoso, S. Kyriakides, S. Ohno, Frédérique Penault‐Llorca, Philip Poortmans, Isabel T. Rubio, Sophia Zackrisson, Elżbieta Senkus

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Errata/Corrigenda

Tiaki ki tētahi rārangi

I tiakina i:
9

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up mā Elżbieta Senkus, S. Kyriakides, Frédérique Penault‐Llorca, Philip Poortmans, Alastair M. Thompson, Sophia Zackrisson, Fátima Cardoso

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Erratum to “Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up” mā Fátima Cardoso, S. Kyriakides, Shinji Ohno, Frédérique Penault‐Llorca, Philip Poortmans, Isabel T. Rubio, Sophia Zackrisson, Elżbieta Senkus

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Errata/Corrigenda

Tiaki ki tētahi rārangi

I tiakina i:
11

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up mā Fátima Cardoso, S. Kyriakides, Shinji Ohno, Frédérique Penault‐Llorca, Philip Poortmans, Isabel T. Rubio, Sophia Zackrisson, Elżbieta Senkus

I whakaputaina 2019

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers mā Insaf Fkih M’hamed, Maud Privat, Flora Ponelle‐Chachuat, Frédérique Penault‐Llorca, Abderraouf Kénani, Yves‐Jean Bignon

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Leptin and leptin receptor involvement in cancer development: a study on human primary breast carcinoma mā Thierry Jardé, Florence Caldefie-Chézet, Mireille Damez, Florence Mishellany, Frédérique Penault‐Llorca, Jacques Guillot, M.-P. Vasson

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Germline mutations of the E‐cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer mā Zeming Xie, Lai Sheng Li, Claire Laquet, Frédérique Penault‐Llorca, Nancy Uhrhammer, Xiao Xie, Yves Jean Bignon

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

SIRT1-dependent epigenetic regulation of H3 and H4 histone acetylation in human breast cancer mā Khaldoun Rifaï, Gaëlle Judes, Mouhamed Idrissou, Marine Daures, Yves‐Jean Bignon, Frédérique Penault‐Llorca, Dominique Bernard-Gallon

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Implementing TMB measurement in clinical practice: considerations on assay requirements mā Reinhard Büttner, John Longshore, Fernando López‐Ríos, Sabine Merkelbach‐Bruse, Nicola Normanno, Etienne Rouleau, Frédérique Penault‐Llorca

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up mā Elżbieta Senkus, S. Kyriakides, Shinji Ohno, Frédérique Penault‐Llorca, Philip Poortmans, Emiel J. Rutgers, Sophia Zackrisson, Fátima Cardoso

I whakaputaina 2015

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study mā Marc J. van de Vijver, Michael Bilous, Wedad Hanna, Manfred Hofmann, Petra Kristel, Frédérique Penault‐Llorca, Josef Rüschoff

I whakaputaina 2007

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies mā Thierry Jardé, Florence Caldefie-Chézet, Nicolas Gonçalves-Mendes, Florence Mishellany, Christa Buechler, Frédérique Penault‐Llorca, M.-P. Vasson

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

Progresses Toward Precision Medicine in<i>RET</i>-altered Solid Tumors mā Carmen Belli, Santosh Anand, Justin F. Gainor, Frédérique Penault‐Llorca, Vivek Subbiah, Alexander Drilon, Fabrice André, Giuseppe Curigliano

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Frédérique Penault‐Llorca

Pathological and molecular diagnosis of triple-negative breast cancer: a clinical perspective mā Frédérique Penault‐Llorca, Giuseppe Viale

aHIF but not HIF-1α transcript is a poor prognostic marker in human breast cancer mā Anne Cayre, Fabrice Rossignol, Eric Clottes, Frédérique Penault‐Llorca

Testing algorithm for identification of patients with TRK fusion cancer mā Frédérique Penault‐Llorca, Erin R. Rudzinski, Antonia R. Sepulveda

Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells mā Abderrahim El Guerrab, Mahchid Bamdad, Yves‐Jean Bignon, Frédérique Penault‐Llorca, Corinne Aubel

Treatment of gastric adenocarcinoma: A rapidly evolving landscape mā Julien Taı̈eb, Jaafar Bennouna, Frédérique Penault-Llorca, Debora Basile, Emmanuelle Samalin, Aziz Zaanan

Experts' opinion: Recommendations for retesting breast cancer metastases for HER2 and hormone receptor status mā Frédérique Penault‐Llorca, Renata A. Coudry, Wedad Hanna, R. Yoshiyuki Osamura, Josef Rüschoff, Giuseppe Viale

Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer mā Abderrahim El Guerrab, Mahchid Bamdad, Fabrice Kwiatkowski, Yves‐Jean Bignon, Frédérique Penault‐Llorca, Corinne Aubel

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up mā Fátima Cardoso, S. Kyriakides, S. Ohno, Frédérique Penault‐Llorca, Philip Poortmans, Isabel T. Rubio, Sophia Zackrisson, Elżbieta Senkus

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up mā Elżbieta Senkus, S. Kyriakides, Frédérique Penault‐Llorca, Philip Poortmans, Alastair M. Thompson, Sophia Zackrisson, Fátima Cardoso

Erratum to “Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up” mā Fátima Cardoso, S. Kyriakides, Shinji Ohno, Frédérique Penault‐Llorca, Philip Poortmans, Isabel T. Rubio, Sophia Zackrisson, Elżbieta Senkus

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up mā Fátima Cardoso, S. Kyriakides, Shinji Ohno, Frédérique Penault‐Llorca, Philip Poortmans, Isabel T. Rubio, Sophia Zackrisson, Elżbieta Senkus

Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers mā Insaf Fkih M’hamed, Maud Privat, Flora Ponelle‐Chachuat, Frédérique Penault‐Llorca, Abderraouf Kénani, Yves‐Jean Bignon

Leptin and leptin receptor involvement in cancer development: a study on human primary breast carcinoma mā Thierry Jardé, Florence Caldefie-Chézet, Mireille Damez, Florence Mishellany, Frédérique Penault‐Llorca, Jacques Guillot, M.-P. Vasson

Germline mutations of the E‐cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer mā Zeming Xie, Lai Sheng Li, Claire Laquet, Frédérique Penault‐Llorca, Nancy Uhrhammer, Xiao Xie, Yves Jean Bignon

SIRT1-dependent epigenetic regulation of H3 and H4 histone acetylation in human breast cancer mā Khaldoun Rifaï, Gaëlle Judes, Mouhamed Idrissou, Marine Daures, Yves‐Jean Bignon, Frédérique Penault‐Llorca, Dominique Bernard-Gallon

Implementing TMB measurement in clinical practice: considerations on assay requirements mā Reinhard Büttner, John Longshore, Fernando López‐Ríos, Sabine Merkelbach‐Bruse, Nicola Normanno, Etienne Rouleau, Frédérique Penault‐Llorca

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up mā Elżbieta Senkus, S. Kyriakides, Shinji Ohno, Frédérique Penault‐Llorca, Philip Poortmans, Emiel J. Rutgers, Sophia Zackrisson, Fátima Cardoso

Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study mā Marc J. van de Vijver, Michael Bilous, Wedad Hanna, Manfred Hofmann, Petra Kristel, Frédérique Penault‐Llorca, Josef Rüschoff

Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies mā Thierry Jardé, Florence Caldefie-Chézet, Nicolas Gonçalves-Mendes, Florence Mishellany, Christa Buechler, Frédérique Penault‐Llorca, M.-P. Vasson

Progresses Toward Precision Medicine in<i>RET</i>-altered Solid Tumors mā Carmen Belli, Santosh Anand, Justin F. Gainor, Frédérique Penault‐Llorca, Vivek Subbiah, Alexander Drilon, Fabrice André, Giuseppe Curigliano

Ngā utauta rapu:

Ngā marau whai pānga